OnCore Login

Return to Trial Database

BRE98-1

Combined anti-microtubule therapy: A phase II study of weekly docetaxel plus estramustine in patients with metastatic breast cancer, Hoosier Oncology Group BRE98-1

Status

Study Completed

Cancer Type(s)

Breast

Study Contact

Publications

Combined anti-microtubule therapy: a phase II study of weekly docetaxel plus estramustine in patients with metastatic breast cancer
  • SE Soule, KD Miller, P Porcu, R Ansari, F Fata, JW McClean, R Zon, GW Sledge, LH Einhorn

Trial Locations

All sites in which the trial BRE98-1 being conducted in.
No data was found
  • 7676 Interactive Way, Suite 120, Indianapolis, IN 46278